Recursion Pharmaceuticals, Inc.宣布将于2025年12月8日举行网络研讨会,以发布关于Rec-4881在家族性腺瘤性息肉病的Tupelo 1B/2期临床试验的最新数据。
Recursion Pharmaceuticals, Inc.宣布将于2025年12月8日举行网络研讨会,以发布关于Rec-4881在家族性腺瘤性息肉病的Tupelo 1B/2期临床试验的最新数据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.